Legal Representation
Attorney
MATTHEW J. GIPSON
USPTO Deadlines 3 active 1 overdue
| Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
|---|---|---|---|---|---|
|
OPPOSITION
Notice of Publication |
NPUB | Nov 21, 2024 | 228 days overdue | Medium | Until Dec 21, 2024 |
|
MAINTENANCE
Section 8 (6-Year) Declaration Due (Based on registration date 2024-12-24) |
R.PR | Dec 24, 2030 | 1996 days | Critical | No |
|
MAINTENANCE
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2024-12-24) |
R.PR | Dec 24, 2034 | 3457 days | Critical | No |
Next deadline: Section 8 (6-Year) Declaration Due (Based on registration date 2024-12-24)
on December 24, 2030
(1996 days)
Application History
17 events| Date | Code | Type | Description |
|---|---|---|---|
| Apr 22, 2025 | PETC | T | CANCELLATION INSTITUTED NO. 999999 |
| Mar 13, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Dec 24, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Dec 24, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Oct 22, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Oct 22, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Oct 2, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Sep 12, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sep 11, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sep 11, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Sep 11, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sep 9, 2024 | GEAN | O | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Sep 9, 2024 | EPEN | O | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY |
| Sep 9, 2024 | CPEA | R | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED |
| Sep 9, 2024 | GEAP | F | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Sep 5, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Sep 3, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 035
retail pharmacy services; on-line retail store services featuring prescription medicines; mail order pharmacy services; pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies
First Use Anywhere:
Jul 1, 2024
First Use in Commerce:
Jul 1, 2024
Class 044
preparation of prescriptions by pharmacists
First Use Anywhere:
Jul 1, 2024
First Use in Commerce:
Jul 1, 2024
Additional Information
Design Mark
The mark consists of the words "MV MEDIVERA COMPOUNDING PHARMACY" with the letter "V" superimposed over the letter "M" and the word "MEDIVERA" stacked above the words "COMPOUNDING PHARMACY" to the right of the "MV" element.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
MEDI VERA MEDI VERA COMPOUNDING PHARMACY
Classification
International Classes
035
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"COMPOUNDING PHARMACY"